Vivos Therapeutics, Inc.
VVOS
$2.60
$0.031.17%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.57M | -12.04M | -15.64M | -13.58M | -15.41M |
| Total Depreciation and Amortization | 586.00K | 589.00K | 592.00K | 621.00K | 641.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.20M | -519.00K | 695.00K | -1.85M | -1.27M |
| Change in Net Operating Assets | -1.72M | 862.00K | 3.43M | 2.86M | 3.84M |
| Cash from Operations | -12.50M | -11.11M | -10.92M | -11.95M | -12.20M |
| Capital Expenditure | -568.00K | -530.00K | -715.00K | -853.00K | -888.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -568.00K | -530.00K | -715.00K | -853.00K | -888.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.74M | 15.44M | 7.94M | 12.00M | 8.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.35M | -838.00K | -738.00K | -1.08M | -645.00K |
| Cash from Financing | 18.39M | 14.60M | 7.20M | 10.92M | 7.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.32M | 2.96M | -4.44M | -1.88M | -5.73M |
